# Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

> **NCT00607230** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 25 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** BCG
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT00607230
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607230, "Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00607230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*